Jane Street’s Genomic Health, Inc. GHDX Stock Holding History

Jane Street’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-9,007	Closed	-$611K	–	6158
2019 Q3	$611K	Buy	+9,007	New	+$619K	﹤0.01%	3283
2017 Q4	–	Sell	-7,074	Closed	-$227K	–	5454
2017 Q3	$227K	Buy	+7,074	New	+$223K	﹤0.01%	3999
2014 Q2	–	Sell	-10,534	Closed	-$277K	–	3335
2014 Q1	$277K	Buy	+10,534	New	+$302K	﹤0.01%	2055
2013 Q4	–	Sell	-12,444	Closed	-$381K	–	3103
2013 Q3	$381K	Buy	+12,444	New	+$416K	﹤0.01%	1912

Jane Street's GHDX Position: Q4 2019 in Review

Jane Street sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 9,007 shares — an estimated $611K sold.

Jane Street first reported a position in GHDX in Q3 2013 and held it in 4 quarters. The position peaked at $611K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Jane Street reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Jane Street sold 9,007 Genomic Health, Inc. shares in Q4 2019, an estimated $611K.
Jane Street first reported a position in Genomic Health, Inc. in Q3 2013 and held it in 4 quarters.
Jane Street's Genomic Health, Inc. position peaked at $611K in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Jane Street's 13F filing for Q4 2019, filed 14 Feb 2020.